Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilie Ammitzbøll

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Immunology (Orlando, Fla.)|August 5, 2021
Assessment of commonly used methods to determine myelin-reactivity of T cells in multiple sclerosisMarina Rode von Essen, Cecilie Ammitzbøll, Lars Börnsen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 7, 2022
Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple SclerosisMarina Rode von Essen, Rikke Holm Hansen, Camilla Højgaard, et al.
Journal of Neuroimmunology|December 9, 2019
MAIT cell subtypes in multiple sclerosisCecilie Ammitzbøll, Marina R von Essen, Helene Højsgaard Chow, et al.
Journal of Neuroimmunology|March 11, 2019
Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activationCecilie Ammitzbøll, Lars Börnsen, Eva Rosa Petersen, et al.
Multiple Sclerosis and Related Disorders|July 25, 2021
Biomarkers of systemic inflammation, soluble IL-2Rα and the multiple sclerosis-associated IL2RA SNP rs2104286 in healthy subjects and multiple sclerosis patientsSophie Buhelt, Helle Bach Søndergaard, Mie Reith Mahler, et al.
Multiple Sclerosis and Related Disorders|May 13, 2021
Natalizumab differentially affects plasmablasts and B cells in multiple sclerosisAlexander Cuculiza Henriksen, Cecilie Ammitzbøll, Eva Rosa Petersen, et al.
Journal of Leukocyte Biology|February 10, 2017
Smoking reduces circulating CD26<sup>hi</sup>CD161<sup>hi</sup> MAIT cells in healthy individuals and patients with multiple sclerosisCecilie Ammitzbøll, Lars Börnsen, Jeppe Romme Christensen, et al.
Brain and Behavior|February 28, 2018
Progressive multiple sclerosis, cognitive function, and quality of lifeHelene Højsgaard Chow, Karen Schreiber, Melinda Magyari, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 14, 2016
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington diseaseTua Vinther-Jensen, Lars Börnsen, Esben Budtz-Jørgensen, et al.
Brain : a Journal of Neurology|December 19, 2018
Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosisMarina R von Essen, Cecilie Ammitzbøll, Rikke H Hansen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Immunology (Orlando, Fla.)|August 5, 2021
Assessment of commonly used methods to determine myelin-reactivity of T cells in multiple sclerosisMarina Rode von Essen, Cecilie Ammitzbøll, Lars Börnsen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 7, 2022
Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple SclerosisMarina Rode von Essen, Rikke Holm Hansen, Camilla Højgaard, et al.
Journal of Neuroimmunology|December 9, 2019
MAIT cell subtypes in multiple sclerosisCecilie Ammitzbøll, Marina R von Essen, Helene Højsgaard Chow, et al.
Journal of Neuroimmunology|March 11, 2019
Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activationCecilie Ammitzbøll, Lars Börnsen, Eva Rosa Petersen, et al.
Multiple Sclerosis and Related Disorders|July 25, 2021
Biomarkers of systemic inflammation, soluble IL-2Rα and the multiple sclerosis-associated IL2RA SNP rs2104286 in healthy subjects and multiple sclerosis patientsSophie Buhelt, Helle Bach Søndergaard, Mie Reith Mahler, et al.
Multiple Sclerosis and Related Disorders|May 13, 2021
Natalizumab differentially affects plasmablasts and B cells in multiple sclerosisAlexander Cuculiza Henriksen, Cecilie Ammitzbøll, Eva Rosa Petersen, et al.
Journal of Leukocyte Biology|February 10, 2017
Smoking reduces circulating CD26<sup>hi</sup>CD161<sup>hi</sup> MAIT cells in healthy individuals and patients with multiple sclerosisCecilie Ammitzbøll, Lars Börnsen, Jeppe Romme Christensen, et al.
Brain and Behavior|February 28, 2018
Progressive multiple sclerosis, cognitive function, and quality of lifeHelene Højsgaard Chow, Karen Schreiber, Melinda Magyari, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 14, 2016
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington diseaseTua Vinther-Jensen, Lars Börnsen, Esben Budtz-Jørgensen, et al.
Brain : a Journal of Neurology|December 19, 2018
Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosisMarina R von Essen, Cecilie Ammitzbøll, Rikke H Hansen, et al.
Pageof 2